Healthcare provider profile · identity verified

John E. Piatt, M.D.

Family Practice · STATE COLLEGE, PA · NPI 1891750915

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	773	219
Amlodipine Besylate	Amlodipine Besylate	482	146
Lisinopril	Lisinopril	458	137
Levothyroxine Sodium	Levothyroxine Sodium	285	75
Omeprazole	Omeprazole	280	73
Metformin Hcl Er	Metformin Hcl	257	80
Rosuvastatin Calcium	Rosuvastatin Calcium	251	78
Pantoprazole Sodium	Pantoprazole Sodium	196	55
Metoprolol Succinate	Metoprolol Succinate	193	54
Metformin Hcl	Metformin Hcl	189	47
Losartan Potassium	Losartan Potassium	159	54
Famotidine	Famotidine	156	44
Jardiance	Empagliflozin	149	34
Gabapentin	Gabapentin	136	44
Alendronate Sodium	Alendronate Sodium	130	29
Indapamide	Indapamide	130	35
Fluticasone Propionate	Fluticasone Propionate	120	41
Trazodone Hcl	Trazodone Hcl	119	30
Hydrochlorothiazide	Hydrochlorothiazide	118	38
Simvastatin	Simvastatin	112	31
Ezetimibe	Ezetimibe	111	34
Eliquis	Apixaban	101	22
Albuterol Sulfate Hfa	Albuterol Sulfate	100	46
Duloxetine Hcl	Duloxetine Hcl	92	25
Tamsulosin Hcl	Tamsulosin Hcl	88	24
Furosemide	Furosemide	86	24
Warfarin Sodium	Warfarin Sodium	86	24
Ozempic	Semaglutide	85	12
Tramadol Hcl	Tramadol Hcl	78	20
Clopidogrel	Clopidogrel Bisulfate	76	19
Allopurinol	Allopurinol	74	20
Alprazolam	Alprazolam	71	17
Candesartan Cilexetil	Candesartan Cilexetil	71	16
Sertraline Hcl	Sertraline Hcl	68	20
Lorazepam	Lorazepam	64	22
Venlafaxine Hcl Er	Venlafaxine Hcl	64	13
Metoprolol Tartrate	Metoprolol Tartrate	63	21
Atenolol	Atenolol	59	17
Prednisone	Prednisone	56	27
Montelukast Sodium	Montelukast Sodium	55	16
Potassium Chloride	Potassium Chloride	54	16
Escitalopram Oxalate	Escitalopram Oxalate	53	16
Citalopram Hbr	Citalopram Hydrobromide	52	13
Mirtazapine	Mirtazapine	52	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	13
Buspirone Hcl	Buspirone Hcl	49	14
Carvedilol	Carvedilol	48	15
Bupropion Hcl Sr	Bupropion Hcl	46	12
Meloxicam	Meloxicam	45	13
Trulicity	Dulaglutide	45	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	43	11
Spironolactone	Spironolactone	43	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	42	suppressed
Oxycodone Hcl	Oxycodone Hcl	39	suppressed
Finasteride	Finasteride	38	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	12
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Baclofen	Baclofen	35	12
Ropinirole Hcl	Ropinirole Hcl	34	11
Valacyclovir	Valacyclovir Hcl	34	11
Naproxen	Naproxen	33	11
Ondansetron Hcl	Ondansetron Hcl	33	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Pregabalin	Pregabalin	30	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	27	27
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Carbamazepine	Carbamazepine	26	suppressed
Clonazepam	Clonazepam	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Glipizide Er	Glipizide	25	suppressed
Terazosin Hcl	Terazosin Hcl	25	suppressed
Celecoxib	Celecoxib	23	suppressed
Jantoven	Warfarin Sodium	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	18
Diazepam	Diazepam	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	11
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Valsartan	Valsartan	20	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	14
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Linzess	Linaclotide	15	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Desloratadine	Desloratadine	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Neupro	Rotigotine	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Topiramate	Topiramate	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Memantine Hcl	Memantine Hcl	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Pravastatin Sodium	Pravastatin Sodium	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error